$0.43
-0.02 (-3.44%)
Open$0.46
Previous Close$0.45
Day High$0.46
Day Low$0.43
52W High$2.56
52W Low$0.45
Volume—
Avg Volume160.5K
Market Cap5.40M
P/E Ratio—
EPS$-0.29
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+6,324.3% upside
Current
$0.43
$0.43
Target
$27.92
$27.92
$15.39
$27.92 avg
$30.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 57.27M | 70.23M | 3.60M |
| Net Income | -6,090,911 | -6,722,859 | 438.1K |
| Profit Margin | -10.6% | -10.1% | 12.2% |
| EBITDA | -3,093,472 | -3,604,118 | 810.0K |
| Free Cash Flow | — | — | 302.1K |
| Rev Growth | -18.5% | -18.5% | +16.0% |
| Debt/Equity | — | — | 0.63 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |